The global proton therapy market size accounted for US$ 452.33 Bn in 2021 and is projected to reach around USD 1.9Bn by 2030, growing at a CAGR of 17.29% from 2022 to 2030.
Report Summary
The global proton therapy market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the proton therapy market across the globe.
A comprehensive estimate on the proton therapy market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of proton therapy during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2337
Proton Therapy Market Report Scope
Report Coverage | Details |
Market Size in 2022 | USD 530.53 million |
Market Size by 2030 | USD 1.9 Billion |
Growth Rate from 2022 to 2030 | CAGR of 17.29% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered |
|
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized proton therapy market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Sodium-Ion Batteries Market Size Analysis 2022 To 2030
Proton Therapy Market Players
The report includes the profiles of key proton therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area are
- IBA Worldwide
- Varian medical systems, Inc
- HItachi, Ltd
- Mevion medical systems
- Sumitomo Heavy Industries, Ltd
- Optivus Proton Therapy
- Advanced Oncotherapy plc
- ProTom International
- Mitsubishi Corporation
- ProNova Solutions LLC
- Sun Nuclear Corporation
- Provision Healthcare
- Koninklijke Philips N.V
- Elekta AB
- GE Healthcare
- Best Cyclotron Systems
- Ray Search Laboratories
- Permedics
Market Segmentation
By Indication
- Breast cancer
- Prostate cancer
- CNS cancer
- Head and Neck cancer
- Others
By Product
- Accelerator
- Beam transport system
- Bean delivery system
- Nozzle and image viewers
- Patient positioning system
By Type
- Rotating Proton Therapy Systems
- Non-Rotating Proton Therapy Systems
By Set-Up Systems
- Multi-Room Systems
- Compact/ Single-Room Systems
By Application Type
- Treatment Applications
- Research Applications
By End-User
- Hospitals
- Proton therapy center
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Proton Therapy Market
5.1. COVID-19 Landscape: Proton Therapy Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Proton Therapy Market, By Indication
8.1. Proton Therapy Market, by Indication, 2022-2030
8.1.1. Breast cancer
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Prostate cancer
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. CNS cancer
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Head and Neck cancer
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Proton Therapy Market, By Product
9.1. Proton Therapy Market, by Product, 2022-2030
9.1.1. Tence
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Beam transport system
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Bean delivery system
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Nozzle and image viewers
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Patient positioning system
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Proton Therapy Market, By Type
10.1. Proton Therapy Market, by Type, 2022-2030
10.1.1. Rotating Proton Therapy Systems
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Rotating Proton Therapy Systems
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Proton Therapy Market, By Set-Up Systems
11.1. Proton Therapy Market, by Set-Up Systems, 2022-2030
11.1.1. Multi-Room Systems
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Compact/ Single-Room Systems
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Proton Therapy Market, By Application Type
12.1. Proton Therapy Market, by Application Type, 2022-2030
12.1.1. Treatment Applications
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Research Applications
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Proton Therapy Market, By End-User
13.1. Proton Therapy Market, by End-User, 2022-2030
13.1.1. Hospitals
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Proton therapy center
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Others
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Proton Therapy Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.6. Market Revenue and Forecast, by End-User (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.8.1. Market Revenue and Forecast, by End-User (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.10. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.11. Market Revenue and Forecast, by End-User (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.6. Market Revenue and Forecast, by End-User (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.9. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.10. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.10.1. Market Revenue and Forecast, by End-User (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.12. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.13. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.14. Market Revenue and Forecast, by End-User (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.16. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.16.1. Market Revenue and Forecast, by End-User (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.18. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.18.1. Market Revenue and Forecast, by End-User (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.6. Market Revenue and Forecast, by End-User (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.9. Market Revenue and Forecast, by End-User (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.11. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.11.1. Market Revenue and Forecast, by End-User (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.12.6. Market Revenue and Forecast, by End-User (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.13.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.9. Market Revenue and Forecast, by End-User (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.11. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.12. Market Revenue and Forecast, by End-User (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.13.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.14.6. Market Revenue and Forecast, by End-User (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.6. Market Revenue and Forecast, by End-User (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.8.1. Market Revenue and Forecast, by End-User (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.9.6. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 15. Company Profiles
15.1. IBA Worldwide
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Varian medical systems, Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. HItachi, Ltd
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Mevion medical systems
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Sumitomo Heavy Industries, Ltd
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Optivus Proton Therapy
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Advanced Oncotherapy plc
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. ProTom International
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Mitsubishi Corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. ProNova Solutions LLC
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com